Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1. Lancets Market, by Type, 2016-2026 (USD Million)
1.3.2. Lancets Market, by Application, 2016-2026 (USD Million)
1.3.3. Lancets Market, by End-User, 2016-2026 (USD Million)
1.3.4. Lancets Market, by Region, 2016-2026 (USD Million)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lancets Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lancets Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Lancets Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Lancets Market, by Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Lancets Market, Sub Segment Analysis
5.3.1. Safety lancets
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.1.3.1 Push-Button Lancets
5.3.1.3.2 Pressure-Activated Lancets
5.3.1.3.3 Side-Buttoned Lancets
5.3.2. Personal Lancets
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 6. Global Lancets Market, by Application
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Lancets Market, Sub Segment Analysis
6.3.1. Glucose Testing
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.2. Haemoglobin Testing
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.3. Coagulation Testing
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.4. Other Applications
6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 7. Global Lancets Market, by End-User
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Lancets Market, Sub Segment Analysis
7.3.1. Hospitals & Clinics
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2. Home Care Settings
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.3. Others
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 8. Global Lancets Market, by Regional Analysis
8.1. Lancets Market, Regional Market Snapshot (2016-2026)
8.2. North America Lancets Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3. Europe Lancets Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.2. Rest of Europe
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4. Asia Lancets Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.3.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.4.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5. Latin America Lancets Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)

8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6. Rest of The World
8.6.1. Middle East and Africa
8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Becton, Dickinson and Company
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Roche Diagnostics
9.3.3. Ypsomed
9.3.4. B. Braun Melsungen
9.3.5. Terumo Corporation
9.3.6. Own Mumford
9.3.7. HTL-STREFA S.A
9.3.8. ARKRAY
9.3.9. Sarstedt
9.3.10. SteriLance Medical
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption